|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
US5240848A
(en)
|
1988-11-21 |
1993-08-31 |
Monsanto Company |
Dna sequences encoding human vascular permeability factor having 189 amino acids
|
|
US5328470A
(en)
|
1989-03-31 |
1994-07-12 |
The Regents Of The University Of Michigan |
Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
|
|
US5332671A
(en)
|
1989-05-12 |
1994-07-26 |
Genetech, Inc. |
Production of vascular endothelial cell growth factor and DNA encoding same
|
|
US5219739A
(en)
|
1989-07-27 |
1993-06-15 |
Scios Nova Inc. |
DNA sequences encoding bVEGF120 and hVEGF121 and methods for the production of bovine and human vascular endothelial cell growth factors, bVEGF120 and hVEGF121
|
|
US5194596A
(en)
|
1989-07-27 |
1993-03-16 |
California Biotechnology Inc. |
Production of vascular endothelial cell growth factor
|
|
ATE162219T1
(de)
|
1989-11-16 |
1998-01-15 |
Univ Duke |
Transformation von tierischen hautzellen mit hilfe von partikeln
|
|
US5610289A
(en)
|
1990-07-27 |
1997-03-11 |
Isis Pharmaceuticals, Inc. |
Backbone modified oligonucleotide analogues
|
|
US5672697A
(en)
|
1991-02-08 |
1997-09-30 |
Gilead Sciences, Inc. |
Nucleoside 5'-methylene phosphonates
|
|
US5252479A
(en)
|
1991-11-08 |
1993-10-12 |
Research Corporation Technologies, Inc. |
Safe vector for gene therapy
|
|
US5587308A
(en)
|
1992-06-02 |
1996-12-24 |
The United States Of America As Represented By The Department Of Health & Human Services |
Modified adeno-associated virus vector capable of expression from a novel promoter
|
|
JPH0641183A
(ja)
|
1992-07-23 |
1994-02-15 |
Mitsubishi Kasei Corp |
オリゴヌクレオチド単分子膜
|
|
US5985558A
(en)
|
1997-04-14 |
1999-11-16 |
Isis Pharmaceuticals Inc. |
Antisense oligonucleotide compositions and methods for the inibition of c-Jun and c-Fos
|
|
US6291438B1
(en)
|
1993-02-24 |
2001-09-18 |
Jui H. Wang |
Antiviral anticancer poly-substituted phenyl derivatized oligoribonucleotides and methods for their use
|
|
US5858988A
(en)
|
1993-02-24 |
1999-01-12 |
Wang; Jui H. |
Poly-substituted-phenyl-oligoribo nucleotides having enhanced stability and membrane permeability and methods of use
|
|
JPH08508490A
(ja)
|
1993-03-31 |
1996-09-10 |
スターリング ウィンスロップ インコーポレイティド |
新規５’−置換ヌクレオシド及びそれから得られるオリゴマー
|
|
TW360548B
(en)
|
1993-04-08 |
1999-06-11 |
Powderject Res Ltd |
Products for therapeutic use
|
|
ATE188479T1
(de)
|
1994-06-01 |
2000-01-15 |
Hybridon Inc |
Verzweigte oligonukleotide als pathogenhemmende mittel
|
|
AU2991295A
(en)
|
1994-07-26 |
1996-02-22 |
Kaken Pharmaceutical Co., Ltd. |
Sustance with antiviral activity
|
|
US6383814B1
(en)
|
1994-12-09 |
2002-05-07 |
Genzyme Corporation |
Cationic amphiphiles for intracellular delivery of therapeutic molecules
|
|
WO1996033761A1
(en)
|
1995-04-28 |
1996-10-31 |
Medtronic, Inc. |
Intraparenchymal infusion catheter system
|
|
US6025335A
(en)
|
1995-09-21 |
2000-02-15 |
Lipitek International, Inc. |
L-Nucleoside Dimer Compounds and therapeutic uses
|
|
US5684143A
(en)
|
1996-02-21 |
1997-11-04 |
Lynx Therapeutics, Inc. |
Oligo-2'-fluoronucleotide N3'->P5' phosphoramidates
|
|
US5735814A
(en)
|
1996-04-30 |
1998-04-07 |
Medtronic, Inc. |
Techniques of treating neurodegenerative disorders by brain infusion
|
|
US20080119427A1
(en)
|
1996-06-06 |
2008-05-22 |
Isis Pharmaceuticals, Inc. |
Double Strand Compositions Comprising Differentially Modified Strands for Use in Gene Modulation
|
|
US5898031A
(en)
|
1996-06-06 |
1999-04-27 |
Isis Pharmaceuticals, Inc. |
Oligoribonucleotides for cleaving RNA
|
|
US5849902A
(en)
|
1996-09-26 |
1998-12-15 |
Oligos Etc. Inc. |
Three component chimeric antisense oligonucleotides
|
|
US6177403B1
(en)
|
1996-10-21 |
2001-01-23 |
The Trustees Of The University Of Pennsylvania |
Compositions, methods, and apparatus for delivery of a macromolecular assembly to an extravascular tissue of an animal
|
|
US6042820A
(en)
|
1996-12-20 |
2000-03-28 |
Connaught Laboratories Limited |
Biodegradable copolymer containing α-hydroxy acid and α-amino acid units
|
|
AUPO974597A0
(en)
|
1997-10-10 |
1997-11-06 |
Rhone-Poulenc Agro |
Methods for obtaining plant varieties
|
|
US6472375B1
(en)
|
1998-04-16 |
2002-10-29 |
John Wayne Cancer Institute |
DNA vaccine and methods for its use
|
|
US6242589B1
(en)
|
1998-07-14 |
2001-06-05 |
Isis Pharmaceuticals, Inc. |
Phosphorothioate oligonucleotides having modified internucleoside linkages
|
|
EP1016726A1
(en)
|
1998-12-30 |
2000-07-05 |
Introgene B.V. |
Gene therapy to promote angiogenesis
|
|
US7608681B2
(en)
|
1999-12-24 |
2009-10-27 |
Genentech, Inc. |
Methods and compositions for prolonging elimination half-times of bioactive compounds
|
|
US8202979B2
(en)
|
2002-02-20 |
2012-06-19 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid
|
|
US8273866B2
(en)
|
2002-02-20 |
2012-09-25 |
Merck Sharp & Dohme Corp. |
RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (SINA)
|
|
US20070026394A1
(en)
|
2000-02-11 |
2007-02-01 |
Lawrence Blatt |
Modulation of gene expression associated with inflammation proliferation and neurite outgrowth using nucleic acid based technologies
|
|
KR100872437B1
(ko)
|
2000-12-01 |
2008-12-05 |
막스-플랑크-게젤샤프트 츄어 푀르더룽 데어 비쎈샤프텐 에.파우. |
Ｒｎａ 간섭을 매개하는 작은 ｒｎａ 분자
|
|
CA2462144C
(en)
|
2001-09-28 |
2016-09-20 |
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. |
Micro-rna molecules
|
|
WO2003053363A2
(en)
|
2001-12-19 |
2003-07-03 |
Millennium Pharmaceuticals, Inc. |
Human diacylglycerol acyltransferase 2 (dgat2) family members and uses therefor
|
|
US20060009409A1
(en)
|
2002-02-01 |
2006-01-12 |
Woolf Tod M |
Double-stranded oligonucleotides
|
|
US20050096284A1
(en)
|
2002-02-20 |
2005-05-05 |
Sirna Therapeutics, Inc. |
RNA interference mediated treatment of polyglutamine (polyQ) repeat expansion diseases using short interfering nucleic acid (siNA)
|
|
US9181551B2
(en)
|
2002-02-20 |
2015-11-10 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
|
|
US20100240730A1
(en)
|
2002-02-20 |
2010-09-23 |
Merck Sharp And Dohme Corp. |
RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (siNA)
|
|
AU2003223775A1
(en)
|
2002-04-30 |
2003-11-17 |
Duke University |
Adeno-associated viral vectors and methods for their production from hybrid adenovirus and for their use
|
|
BRPI0312818B8
(pt)
|
2002-07-19 |
2021-05-25 |
Beth Israel Deaconess Medical Ct Inc |
uso de uma medida do nível do polipeptídeo sflt-1 em uma amostra de uma paciente e uso de uma medida dos níveis de pelo menos dois dos peptídeos sflt1, vegf livre ou polipeptídio pigf livre em uma amostra de um paciente usando um métrico
|
|
US20050106731A1
(en)
|
2002-08-05 |
2005-05-19 |
Davidson Beverly L. |
siRNA-mediated gene silencing with viral vectors
|
|
US7923547B2
(en)
|
2002-09-05 |
2011-04-12 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
|
|
US8097752B2
(en)
|
2002-10-30 |
2012-01-17 |
Makscientific, Llc |
Antiprotozoal ring-substituted phospholipids
|
|
WO2004043979A2
(en)
|
2002-11-05 |
2004-05-27 |
Isis Pharmaceuticals, Inc. |
Sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
|
|
WO2006006948A2
(en)
|
2002-11-14 |
2006-01-19 |
Dharmacon, Inc. |
METHODS AND COMPOSITIONS FOR SELECTING siRNA OF IMPROVED FUNCTIONALITY
|
|
US7250496B2
(en)
|
2002-11-14 |
2007-07-31 |
Rosetta Genomics Ltd. |
Bioinformatically detectable group of novel regulatory genes and uses thereof
|
|
JP2006507841A
(ja)
|
2002-11-14 |
2006-03-09 |
ダーマコン， インコーポレイテッド |
機能的ｓｉＲＮＡおよび超機能的ｓｉＲＮＡ
|
|
US7790867B2
(en)
|
2002-12-05 |
2010-09-07 |
Rosetta Genomics Inc. |
Vaccinia virus-related nucleic acids and microRNA
|
|
US6913890B2
(en)
|
2002-12-18 |
2005-07-05 |
Palo Alto Research Center Incorporated |
Process for preparing albumin protein conjugated oligonucleotide probes
|
|
WO2004061081A2
(en)
|
2002-12-27 |
2004-07-22 |
Ichem Technologies |
Sirna compounds and methods for the downregulation of gene expression
|
|
US20040198640A1
(en)
|
2003-04-02 |
2004-10-07 |
Dharmacon, Inc. |
Stabilized polynucleotides for use in RNA interference
|
|
JP4597976B2
(ja)
|
2003-04-17 |
2010-12-15 |
アルナイラム ファーマシューティカルズ インコーポレイテッド |
修飾ｉＲＮＡ剤
|
|
AU2004252442B2
(en)
|
2003-06-02 |
2010-04-08 |
University Of Massachusetts |
Methods and compositions for enhancing the efficacy and specificity of FNAi
|
|
US7750144B2
(en)
|
2003-06-02 |
2010-07-06 |
University Of Massachusetts |
Methods and compositions for enhancing the efficacy and specificity of RNA silencing
|
|
ES2712695T3
(es)
|
2003-06-02 |
2019-05-14 |
Univ Massachusetts |
Métodos y composiciones para controlar la eficacia de la silenciación del ARN
|
|
DE10326302A1
(de)
|
2003-06-11 |
2004-12-30 |
Gnothis Holding Sa |
Bi-Fluorophor-markierte Sonden zum Nachweis von Nukleinsäuren
|
|
WO2004113496A2
(en)
|
2003-06-20 |
2004-12-29 |
Isis Pharmaceuticals, Inc. |
Double stranded compositions comprising a 3’-endo modified strand for use in gene modulation
|
|
US8680063B2
(en)
|
2003-09-12 |
2014-03-25 |
University Of Massachusetts |
RNA interference for the treatment of gain-of-function disorders
|
|
SG146682A1
(en)
|
2003-09-18 |
2008-10-30 |
Isis Pharmaceuticals Inc |
Modulation of eif4e expression
|
|
CN1906308B
(zh)
|
2003-12-19 |
2011-09-14 |
诺华疫苗和诊断公司 |
小干扰rna的细胞转染制剂、相关组合物以及制备和使用方法
|
|
US20050176045A1
(en)
|
2004-02-06 |
2005-08-11 |
Dharmacon, Inc. |
SNP discriminatory siRNA
|
|
US20060078542A1
(en)
|
2004-02-10 |
2006-04-13 |
Mah Cathryn S |
Gel-based delivery of recombinant adeno-associated virus vectors
|
|
ES2423060T3
(es)
|
2004-03-12 |
2013-09-17 |
Alnylam Pharmaceuticals, Inc. |
Agentes iRNA que tienen como diana al VEGF
|
|
KR101147147B1
(ko)
*
|
2004-04-01 |
2012-05-25 |
머크 샤프 앤드 돔 코포레이션 |
Ｒｎａ 간섭의 오프 타겟 효과 감소를 위한 변형된폴리뉴클레오타이드
|
|
CA2564616C
(en)
|
2004-04-20 |
2016-08-30 |
Nastech Pharmaceutical Company Inc. |
Methods and compositions for enhancing delivery of double-stranded rna or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cells
|
|
EP1752536A4
(en)
|
2004-05-11 |
2008-04-16 |
Alphagen Co Ltd |
POLYNUCLEOTIDE CAUSING RNA INTERFERENCE AND METHOD OF REGULATING GENE EXPRESSION WITH THE USE OF THE SAME
|
|
JP2008504840A
(ja)
|
2004-06-30 |
2008-02-21 |
アルニラム ファーマスーティカルズ インコーポレイテッド |
非リン酸骨格結合を含むオリゴヌクレオチド
|
|
US7361468B2
(en)
|
2004-07-02 |
2008-04-22 |
Affymetrix, Inc. |
Methods for genotyping polymorphisms in humans
|
|
AU2005316476A1
(en)
|
2004-12-15 |
2006-06-22 |
University Of Florida Research Foundation, Inc. |
Chimeric vectors
|
|
JP2009504782A
(ja)
|
2005-08-18 |
2009-02-05 |
アルナイラム ファーマシューティカルズ インコーポレイテッド |
神経疾患を治療するための方法および組成物
|
|
DK1931780T3
(en)
*
|
2005-08-29 |
2016-01-25 |
Regulus Therapeutics Inc |
Antisense-forbindelser med forøget anti-microrna-aktivitet
|
|
AU2006305886C1
(en)
|
2005-10-28 |
2011-03-17 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of huntingtin gene
|
|
WO2007051303A1
(en)
|
2005-11-02 |
2007-05-10 |
Protiva Biotherapeutics, Inc. |
MODIFIED siRNA MOLECULES AND USES THEREOF
|
|
WO2007056153A2
(en)
|
2005-11-04 |
2007-05-18 |
Nastech Pharmaceutical Company Inc. |
Peptide-dicer substrate rna conjugates as delivery vehicles for sirna
|
|
US7825099B2
(en)
|
2006-01-20 |
2010-11-02 |
Quark Pharmaceuticals, Inc. |
Treatment or prevention of oto-pathologies by inhibition of pro-apoptotic genes
|
|
WO2007087451A2
(en)
|
2006-01-25 |
2007-08-02 |
University Of Massachusetts |
Compositions and methods for enhancing discriminatory rna interference
|
|
US9198981B2
(en)
|
2006-02-01 |
2015-12-01 |
The University Of Kentucky |
Modulation of angiogenesis
|
|
WO2007091269A2
(en)
|
2006-02-08 |
2007-08-16 |
Quark Pharmaceuticals, Inc. |
NOVEL TANDEM siRNAS
|
|
WO2007094218A1
(ja)
|
2006-02-16 |
2007-08-23 |
Gifu University |
修飾オリゴヌクレオチド
|
|
US20100184209A1
(en)
|
2006-02-17 |
2010-07-22 |
Dharmacon, Inc. |
Compositions and methods for inhibiting gene silencing by rna interference
|
|
US20090306178A1
(en)
|
2006-03-27 |
2009-12-10 |
Balkrishen Bhat |
Conjugated double strand compositions for use in gene modulation
|
|
CA2662704A1
(en)
|
2006-07-07 |
2008-01-10 |
University Of Massachusetts |
Rna silencing compositions and methods for the treatment of huntington's disease
|
|
US20080039415A1
(en)
|
2006-08-11 |
2008-02-14 |
Gregory Robert Stewart |
Retrograde transport of sirna and therapeutic uses to treat neurologic disorders
|
|
US8809514B2
(en)
|
2006-09-22 |
2014-08-19 |
Ge Healthcare Dharmacon, Inc. |
Tripartite oligonucleotide complexes and methods for gene silencing by RNA interference
|
|
AU2007310982A1
(en)
|
2006-10-18 |
2008-04-24 |
Marina Biotech, Inc. |
Nicked or gapped nucleic acid molecules and uses thereof
|
|
US8906874B2
(en)
|
2006-11-09 |
2014-12-09 |
Gradalis, Inc. |
Bi-functional shRNA targeting Stathmin 1 and uses thereof
|
|
JP2010510810A
(ja)
|
2006-11-27 |
2010-04-08 |
エンゾン ファーマスーティカルズ インコーポレイテッド |
ポリマー低分子干渉ｒｎａ複合体
|
|
EP2126081A2
(en)
|
2007-03-02 |
2009-12-02 |
MDRNA, Inc. |
Nucleic acid compounds for inhibiting hif1a gene expression and uses thereof
|
|
WO2008154482A2
(en)
|
2007-06-08 |
2008-12-18 |
Sirnaomics, Inc. |
Sirna compositions and methods of use in treatment of ocular diseases
|
|
WO2009002944A1
(en)
*
|
2007-06-22 |
2008-12-31 |
Isis Pharmaceuticals, Inc. |
Double strand compositions comprising differentially modified strands for use in gene modulation
|
|
AU2008290545A1
(en)
|
2007-08-23 |
2009-02-26 |
Novartis Ag |
Methods for detecting oligonucleotides
|
|
EP2193140B1
(en)
|
2007-08-27 |
2016-11-02 |
1Globe Health Institute LLC |
Compositions of asymmetric interfering rna and uses thereof
|
|
CN101199858A
(zh)
|
2007-10-18 |
2008-06-18 |
广州拓谱基因技术有限公司 |
治疗眼科疾病的多靶点小干扰rna鸡尾酒制剂及制备方法
|
|
TW200927177A
(en)
|
2007-10-24 |
2009-07-01 |
Nat Inst Of Advanced Ind Scien |
Lipid-modified double-stranded RNA having potent RNA interference effect
|
|
CN102006890A
(zh)
|
2007-12-04 |
2011-04-06 |
阿尔尼拉姆医药品有限公司 |
靶向脂质
|
|
US9029524B2
(en)
|
2007-12-10 |
2015-05-12 |
California Institute Of Technology |
Signal activated RNA interference
|
|
WO2009099991A2
(en)
|
2008-01-31 |
2009-08-13 |
The Brigham And Women's Hospital, Inc. |
Treatment of cancer
|
|
EP2247729B1
(en)
|
2008-02-11 |
2019-05-01 |
Phio Pharmaceuticals Corp. |
Modified rnai polynucleotides and uses thereof
|
|
US9217155B2
(en)
|
2008-05-28 |
2015-12-22 |
University Of Massachusetts |
Isolation of novel AAV'S and uses thereof
|
|
WO2010008582A2
(en)
|
2008-07-18 |
2010-01-21 |
Rxi Pharmaceuticals Corporation |
Phagocytic cell drug delivery system
|
|
EP2318528A1
(en)
|
2008-07-24 |
2011-05-11 |
Rxi Pharmaceuticals Corporation |
Rnai constructs and uses therof
|
|
CA2732229C
(en)
*
|
2008-07-25 |
2023-10-17 |
Alnylam Pharmaceuticals, Inc. |
Enhancement of sirna silencing activity using universal bases or mismatches in the sense strand
|
|
EP2340309A2
(en)
|
2008-09-22 |
2011-07-06 |
Rxi Pharmaceuticals Corporation |
Neutral nanotransporters
|
|
WO2010043512A1
(en)
|
2008-10-15 |
2010-04-22 |
F. Hoffmann-La Roche Ag |
Oligonucleotide detection method
|
|
CN102994500B
(zh)
|
2008-10-22 |
2015-04-01 |
夸克制药公司 |
治疗眼部疾病的方法
|
|
WO2010048585A2
(en)
|
2008-10-24 |
2010-04-29 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds and methods
|
|
US9074211B2
(en)
|
2008-11-19 |
2015-07-07 |
Rxi Pharmaceuticals Corporation |
Inhibition of MAP4K4 through RNAI
|
|
US9493774B2
(en)
|
2009-01-05 |
2016-11-15 |
Rxi Pharmaceuticals Corporation |
Inhibition of PCSK9 through RNAi
|
|
WO2010083615A1
(en)
|
2009-01-26 |
2010-07-29 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing apolipoprotein c-iii expression
|
|
WO2010090762A1
(en)
|
2009-02-04 |
2010-08-12 |
Rxi Pharmaceuticals Corporation |
Rna duplexes with single stranded phosphorothioate nucleotide regions for additional functionality
|
|
KR101141544B1
(ko)
|
2009-03-13 |
2012-05-03 |
한국과학기술원 |
에스아이알엔에이 다중 접합체 및 이의 제조방법
|
|
EP2411518A2
(en)
|
2009-03-27 |
2012-02-01 |
Merck Sharp&Dohme Corp. |
Rna interference mediated inhibition of the high affinity ige receptor alpha chain (fcerla) gene expression using short interfering nucleic acid (sina)
|
|
US8309356B2
(en)
|
2009-04-01 |
2012-11-13 |
Yale University |
Pseudocomplementary oligonucleotides for targeted gene therapy
|
|
WO2010118263A1
(en)
|
2009-04-08 |
2010-10-14 |
University Of Massachusetts |
Single-nucleotide polymorphism (snp) targeting therapies for the treatment of huntington's disease
|
|
WO2010138263A2
(en)
|
2009-05-28 |
2010-12-02 |
University Of Massachusetts |
Novel aav 's and uses thereof
|
|
GB0910723D0
(en)
|
2009-06-22 |
2009-08-05 |
Sylentis Sau |
Novel drugs for inhibition of gene expression
|
|
SI2470656T1
(sl)
|
2009-08-27 |
2015-07-31 |
Idera Pharmaceuticals, Inc. |
Sestavek za inhibicijo ekspresije genov in njegova uporaba
|
|
RU2562861C2
(ru)
|
2009-09-11 |
2015-09-10 |
Айсис Фармасьютикалс, Инк. |
Модуляция экспрессии гентингтина
|
|
US20150025122A1
(en)
|
2009-10-12 |
2015-01-22 |
Larry J. Smith |
Methods and Compositions for Modulating Gene Expression Using Oligonucleotide Based Drugs Administered in vivo or in vitro
|
|
US8877439B2
(en)
*
|
2009-12-17 |
2014-11-04 |
Sirna Therapeutics, Inc. |
Method for rapidly evaluating performance of short interfering RNA with novel chemical modifications
|
|
EP3561060A1
(en)
|
2010-02-08 |
2019-10-30 |
Ionis Pharmaceuticals, Inc. |
Selective reduction of allelic variants
|
|
WO2011109698A1
(en)
|
2010-03-04 |
2011-09-09 |
Rxi Pharmaceuticals Corporation |
Formulations and methods for targeted delivery to phagocyte cells
|
|
EP2550000A4
(en)
|
2010-03-24 |
2014-03-26 |
Advirna Inc |
RNAI COMPOUNDS OF REDUCED SIZE ADMINISTERING
|
|
BR112012024049A2
(pt)
|
2010-03-24 |
2017-03-01 |
Rxi Pharmaceuticals Corp |
interferência de rna em indicações dérmicas e fibróticas
|
|
CN106074591B
(zh)
|
2010-03-24 |
2020-01-14 |
菲奥医药公司 |
眼部症候中的rna干扰
|
|
WO2011125943A1
(ja)
|
2010-04-01 |
2011-10-13 |
日本新薬株式会社 |
修飾オリゴヌクレオチド
|
|
EP2601204B1
(en)
|
2010-04-28 |
2016-09-07 |
Ionis Pharmaceuticals, Inc. |
Modified nucleosides and oligomeric compounds prepared therefrom
|
|
WO2012005898A2
(en)
|
2010-06-15 |
2012-01-12 |
Alnylam Pharmaceuticals, Inc. |
Chinese hamster ovary (cho) cell transcriptome, corresponding sirnas and uses thereof
|
|
JP5941842B2
(ja)
|
2010-06-18 |
2016-06-29 |
Ｌｓｉｐファンド運営合同会社 |
優性アレル発現抑制剤
|
|
US8586301B2
(en)
|
2010-06-30 |
2013-11-19 |
Stratos Genomics, Inc. |
Multiplexed identification of nucleic acid sequences
|
|
CA2812046A1
(en)
|
2010-09-15 |
2012-03-22 |
Alnylam Pharmaceuticals, Inc. |
Modified irna agents
|
|
EP3766975A1
(en)
|
2010-10-29 |
2021-01-20 |
Sirna Therapeutics, Inc. |
Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina)
|
|
AU2011325956B2
(en)
|
2010-11-12 |
2016-07-14 |
The General Hospital Corporation |
Polycomb-associated non-coding RNAs
|
|
US10378016B2
(en)
|
2010-12-06 |
2019-08-13 |
Children's Medical Center Corporation |
Composition and method for oligonucleotide delivery
|
|
CN103492382A
(zh)
|
2010-12-16 |
2014-01-01 |
沃泰克斯药物股份有限公司 |
流感病毒复制的抑制剂
|
|
KR20130128435A
(ko)
|
2010-12-16 |
2013-11-26 |
버텍스 파마슈티칼스 인코포레이티드 |
인플루엔자 바이러스 복제의 억제제
|
|
AU2011343642A1
(en)
|
2010-12-16 |
2013-05-02 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of influenza viruses replication
|
|
BR112013013434A2
(pt)
|
2010-12-17 |
2016-08-16 |
Arrowhead Res Corp |
metade que tem por alvo modulador fármaco cinético em cacho de galactose para sirna
|
|
WO2012118911A1
(en)
|
2011-03-03 |
2012-09-07 |
Quark Pharmaceuticals, Inc. |
Oligonucleotide modulators of the toll-like receptor pathway
|
|
GB201105137D0
(en)
|
2011-03-28 |
2011-05-11 |
Isis Innovation |
Therapeutic molecules for use in the suppression of Parkinson's disease
|
|
WO2012143796A2
(en)
|
2011-04-21 |
2012-10-26 |
Institut Pasteur Korea |
Anti-inflammation compounds
|
|
EP2723865B1
(en)
|
2011-06-21 |
2019-03-27 |
Alnylam Pharmaceuticals, Inc. |
METHODS FOR DETERMINING ACTIVITY OF RNAi IN A SUBJECT
|
|
EP3358013B1
(en)
|
2012-05-02 |
2020-06-24 |
Sirna Therapeutics, Inc. |
Short interfering nucleic acid (sina) compositions
|
|
DK2853597T3
(en)
|
2012-05-22 |
2019-04-08 |
Olix Pharmaceuticals Inc |
RNA INTERFERENCE-INducing NUCLEIC ACID MOLECULES WITH CELL PENETENING EQUIPMENT AND USE THEREOF
|
|
AU2013288738A1
(en)
|
2012-07-10 |
2015-01-29 |
Baseclick Gmbh |
Anandamide-modified nucleic acid molecules
|
|
CA2884608C
(en)
|
2012-09-14 |
2025-05-20 |
Translate Bio Ma, Inc. |
MULTIMERIC OLIGONUCLEOTIDE COMPOUNDS
|
|
SG10201804331TA
(en)
|
2012-11-15 |
2018-07-30 |
Roche Innovation Ct Copenhagen As |
Oligonucleotide conjugates
|
|
KR102096014B1
(ko)
|
2012-12-05 |
2020-04-03 |
알닐람 파마슈티칼스 인코포레이티드 |
PCSK9 iRNA 조성물 및 그 사용 방법
|
|
EP2931319B1
(en)
|
2012-12-13 |
2019-08-21 |
ModernaTX, Inc. |
Modified nucleic acid molecules and uses thereof
|
|
US20140200124A1
(en)
|
2013-01-15 |
2014-07-17 |
Karen Michelle JAMES |
Physical Therapy Device and Methods for Use Thereof
|
|
CA2921162A1
(en)
|
2013-05-01 |
2014-11-06 |
Ionis Pharmaceuticals, Inc. |
Conjugated antisense compounds and their use
|
|
WO2014201306A1
(en)
|
2013-06-12 |
2014-12-18 |
Oncoimmunin, Inc. |
Systemic in vivo delivery of oligonucleotides
|
|
EP3010514B1
(en)
|
2013-06-16 |
2021-01-20 |
National University Corporation Tokyo Medical and Dental University |
Double-stranded antisense nucleic acid with exon-skipping effect
|
|
US9862350B2
(en)
|
2013-08-12 |
2018-01-09 |
Tk Holdings Inc. |
Dual chambered passenger airbag
|
|
GB201315141D0
(en)
|
2013-08-23 |
2013-10-09 |
Logicor R & D Ltd |
Improvements to electric heating systems and method of use thereof
|
|
WO2015057847A1
(en)
|
2013-10-16 |
2015-04-23 |
Cerulean Pharma Inc. |
Conjugates, particles, compositions, and related methods
|
|
US10752940B2
(en)
|
2013-11-08 |
2020-08-25 |
Ionis Pharmaceuticals, Inc. |
Compounds and methods for detecting oligonucleotides
|
|
EP3099795A4
(en)
|
2014-01-27 |
2018-01-17 |
The Board of Trustees of the Leland Stanford Junior University |
Oligonucleotides and methods for treatment of cardiomyopathy using rna interference
|
|
EP3132044B1
(en)
|
2014-04-18 |
2020-04-08 |
University of Massachusetts |
Exosomal loading using hydrophobically modified oligonucleotides
|
|
MA39941A
(fr)
|
2014-05-01 |
2017-03-08 |
Larry J Smith |
Procédés et modifications permettant de produire des composés arni simple brin à activité, potentiel et durée d'effet améliorés
|
|
WO2015171918A2
(en)
|
2014-05-07 |
2015-11-12 |
Louisiana State University And Agricultural And Mechanical College |
Compositions and uses for treatment thereof
|
|
BR122020023687B1
(pt)
|
2014-05-22 |
2023-03-07 |
Alnylam Pharmaceuticals, Inc |
Agente de ácido ribonucleico (rnai) de fita dupla, seus usos e composição farmacêutica
|
|
US10588980B2
(en)
|
2014-06-23 |
2020-03-17 |
Novartis Ag |
Fatty acids and their use in conjugation to biomolecules
|
|
IL316808A
(en)
*
|
2014-08-20 |
2025-01-01 |
Alnylam Pharmaceuticals Inc |
Modified double-stranded RNA materials and their uses
|
|
US20170327524A1
(en)
|
2014-10-10 |
2017-11-16 |
Hoffmann-La Roche, Inc. |
Galnac phosphoramidites, nucleic acid conjugates thereof and their use
|
|
SG11201703638XA
(en)
|
2014-11-10 |
2017-06-29 |
Alnylam Pharmaceuticals Inc |
Hepatitis b virus (hbv) irna compositions and methods of use thereof
|
|
WO2016083623A1
(en)
|
2014-11-28 |
2016-06-02 |
Silence Therapeutics Gmbh |
Means for the treatment of pre-eclampsia
|
|
EP3237618B1
(en)
|
2014-12-24 |
2019-05-22 |
uniQure IP B.V. |
Rnai induced huntingtin gene suppression
|
|
US10450563B2
(en)
|
2015-02-10 |
2019-10-22 |
Genzyme Corporation |
Variant RNAi
|
|
CA2979703A1
(en)
*
|
2015-03-17 |
2016-09-22 |
Arrowhead Pharmaceuticals, Inc. |
Compositions and methods for inhibiting gene expression of factor xii
|
|
WO2016161388A1
(en)
|
2015-04-03 |
2016-10-06 |
University Of Massachusetts |
Fully stabilized asymmetric sirna
|
|
EP3277815B1
(en)
|
2015-04-03 |
2021-09-22 |
University of Massachusetts |
Oligonucleotide compounds for treatment of preeclampsia and other angiogenic disorders
|
|
JP7009356B2
(ja)
|
2015-04-03 |
2022-01-25 |
ユニバーシティ・オブ・マサチューセッツ |
ハンチンチンｍＲＮＡをターゲティングするオリゴヌクレオチド化合物
|
|
CA2982369A1
(en)
|
2015-04-10 |
2016-10-13 |
Hudsonalpha Institute For Biotechnology |
Method for blocking mirna
|
|
IL316159A
(en)
|
2015-06-15 |
2024-12-01 |
Mpeg La Llc |
Defined Oligonucleotide Multimers and Methods for Manufacture Thereof
|
|
US20170009304A1
(en)
|
2015-07-07 |
2017-01-12 |
Splicingcodes.Com |
Method and kit for detecting fusion transcripts
|
|
WO2017015575A1
(en)
|
2015-07-22 |
2017-01-26 |
Wave Life Sciences Ltd. |
Oligonucleotide compositions and methods thereof
|
|
EP3331573A4
(en)
|
2015-08-06 |
2019-02-27 |
City of Hope |
THERAPEUTIC CELL-INTERNALIZING CONJUGATES
|
|
WO2017030973A1
(en)
|
2015-08-14 |
2017-02-23 |
University Of Massachusetts |
Bioactive conjugates for oligonucleotide delivery
|
|
EP3359523A4
(en)
*
|
2015-10-09 |
2019-07-24 |
Wave Life Sciences Ltd. |
OLIGONUCLEOTIDE COMPOSITIONS AND METHOD THEREFOR
|
|
CN105194689A
(zh)
|
2015-10-10 |
2015-12-30 |
湖南中楚博生物科技有限公司 |
一种基于siRNA的双偶联复合物
|
|
US10478503B2
(en)
|
2016-01-31 |
2019-11-19 |
University Of Massachusetts |
Branched oligonucleotides
|
|
EP3440222B1
(en)
|
2016-04-04 |
2025-02-19 |
F. Hoffmann-La Roche AG |
Nucleic acid sample preparation methods
|
|
US10036024B2
(en)
|
2016-06-03 |
2018-07-31 |
Purdue Research Foundation |
siRNA compositions that specifically downregulate expression of a variant of the PNPLA3 gene and methods of use thereof for treating a chronic liver disease or alcoholic liver disease (ALD)
|
|
US11753638B2
(en)
|
2016-08-12 |
2023-09-12 |
University Of Massachusetts |
Conjugated oligonucleotides
|
|
CA3035293A1
(en)
|
2016-09-01 |
2018-03-08 |
Proqr Therapeutics Ii B.V. |
Chemically modified single-stranded rna-editing oligonucleotides
|
|
RS63836B1
(sr)
*
|
2017-04-05 |
2023-01-31 |
Silence Therapeutics Gmbh |
Proizvodi i sastavi
|
|
CN111050806A
(zh)
|
2017-06-02 |
2020-04-21 |
波涛生命科学有限公司 |
寡核苷酸组合物及其使用方法
|
|
CA3064590A1
(en)
|
2017-06-23 |
2018-12-27 |
University Of Massachusetts |
Two-tailed self-delivering sirna and related methods
|
|
CA3071086A1
(en)
|
2017-08-18 |
2019-02-21 |
The Procter & Gamble Company |
Cleaning agent
|
|
SG11202003310XA
(en)
|
2017-10-12 |
2020-05-28 |
Avery Dennison Corp |
Low outgassing clean adhesive
|
|
IL273875B2
(en)
|
2017-10-13 |
2025-07-01 |
Dicerna Pharmaceuticals Inc |
Methods and compositions for inhibiting expression of ldha
|
|
WO2019099949A1
(en)
|
2017-11-17 |
2019-05-23 |
The Regents Of The University Of California |
Manipulation of the retinoic acid signaling pathway
|
|
EP3550021A1
(en)
*
|
2018-04-05 |
2019-10-09 |
Silence Therapeutics GmbH |
Products and compositions for inhibiting expression of a target gene
|
|
EP3790970A1
(en)
|
2018-05-07 |
2021-03-17 |
Alnylam Pharmaceuticals Inc. |
Extrahepatic delivery
|
|
CN120247995A
(zh)
|
2018-05-30 |
2025-07-04 |
诺华股份有限公司 |
脂质修饰的核酸化合物和方法
|
|
WO2020033899A1
(en)
|
2018-08-10 |
2020-02-13 |
University Of Massachusetts |
Modified oligonucleotides targeting snps
|
|
JP7627042B2
(ja)
|
2018-08-23 |
2025-02-05 |
ユニバーシティー オブ マサチューセッツ |
Ｏ－メチルリッチ完全安定化オリゴヌクレオチド
|
|
WO2020150636A1
(en)
|
2019-01-18 |
2020-07-23 |
University Of Massachusetts |
Dynamic pharmacokinetic-modifying anchors
|
|
AU2020239987A1
(en)
|
2019-03-15 |
2021-11-04 |
University Of Massachusetts |
Oligonucleotides for tissue specific ApoE modulation
|
|
US11820985B2
(en)
|
2019-03-26 |
2023-11-21 |
University Of Massachusetts |
Modified oligonucleotides with increased stability
|
|
EP3946374A4
(en)
|
2019-03-29 |
2023-07-19 |
University of Massachusetts |
OLIGONUCLEOTIDE-BASED MODULATION OF C9ORF72
|
|
CA3149835A1
(en)
|
2019-08-09 |
2021-02-18 |
University Of Massachusetts |
Chemically modified oligonucleotides targeting snps
|
|
WO2021041247A1
(en)
*
|
2019-08-23 |
2021-03-04 |
University Of Massachusetts |
O-methyl rich fully stabilized oligonucleotides
|
|
EP4090744A4
(en)
|
2020-01-17 |
2024-04-10 |
Anastasia Khvorova |
UNIVERSAL DYNAMIC PHARMACOKINETIC MODIFYING ANCHORS
|
|
US12258566B2
(en)
|
2020-02-28 |
2025-03-25 |
University Of Massachusetts |
Oligonucleotides for PRNP modulation
|
|
CA3171246A1
(en)
|
2020-03-18 |
2021-09-23 |
University Of Massachusetts |
Oligonucleotides for mapt modulation
|
|
PL4126040T3
(pl)
|
2020-03-26 |
2025-04-28 |
Nutrivert Inc. |
Lipofilowe enancjomery deacetyloglukozamino–muramylodipeptydu o aktywności przeciwzapalnej i wspomagającej wzrost
|
|
US12146136B2
(en)
|
2020-03-26 |
2024-11-19 |
University Of Massachusetts |
Synthesis of modified oligonucleotides with increased stability
|
|
WO2021195510A1
(en)
|
2020-03-27 |
2021-09-30 |
University Of Massachusetts |
Dual-acting sirna based modulation of c9orf72
|
|
JP2023522701A
(ja)
|
2020-04-20 |
2023-05-31 |
ユニバーシティー オブ マサチューセッツ |
Ｍｓｈ３調節のためのオリゴヌクレオチド
|
|
EP4157289A4
(en)
|
2020-05-26 |
2024-06-26 |
University Of Massachusetts |
Synthetic oligonucleotides having regions of block and cluster modifications
|
|
EP4158028A4
(en)
|
2020-05-28 |
2024-10-02 |
University Of Massachusetts |
OLIGONUCLEOTIDES FOR THE MODULATION OF SARS-COV-2
|
|
CA3174068A1
(en)
|
2020-07-16 |
2022-01-20 |
Anastasia Khvorova |
Conjugated oligonucleotides for tissue specific delivery
|
|
WO2022031591A2
(en)
|
2020-08-03 |
2022-02-10 |
University Of Massachusetts |
Oligonucleotides for htt-1a modulation
|
|
AU2021382621A1
(en)
|
2020-11-23 |
2023-06-22 |
University Of Massachusetts |
Oligonucleotides for dgat2 modulation
|
|
AR126207A1
(es)
|
2021-06-23 |
2023-09-27 |
Univ Massachusetts |
Compuestos de oligonucleotidos anti-flt1 optimizados para el tratamiento de la preeclampsia y otros desordenes angiogénicos
|
|
WO2023014654A2
(en)
|
2021-08-02 |
2023-02-09 |
University Of Massachusetts |
Oligonucleotides for htt-1a modulation
|
|
US20230193281A1
(en)
|
2021-11-08 |
2023-06-22 |
University Of Massachusetts |
Oligonucleotides for sod1 modulation
|
|
WO2023114989A2
(en)
|
2021-12-17 |
2023-06-22 |
University Of Massachusetts |
Oligonucleotides for mlh3 modulation
|
|
US20230340475A1
(en)
|
2021-12-17 |
2023-10-26 |
University Of Massachusetts |
Oligonucleotides for mlh1 modulation
|
|
WO2023133550A2
(en)
|
2022-01-10 |
2023-07-13 |
University Of Massachusetts |
Oligonucleotides for mecp2 modulation
|
|
US20230392146A1
(en)
|
2022-03-11 |
2023-12-07 |
University Of Massachusetts |
Oligonucleotides for app modulation
|
|
WO2023201281A2
(en)
|
2022-04-14 |
2023-10-19 |
University Of Massachusetts |
Oligonucleotides for atn1 modulation
|
|
CN120076786A
(zh)
|
2022-09-30 |
2025-05-30 |
马萨诸塞大学 |
寡核苷酸的经眼递送
|